Trial Condition(s):

Dermatitis, Atopic

Study to compare the efficacy and safety of Advantan ointment once daily with Protopic 0.03% ointment twice daily in children and adolescents with atopic dermatitis

Bayer Identifier:

Trial_308962

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
265
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information